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Edited by Laszlo NagyAbstract Using MIN6 b-cells and chromatin immunoprecipita-
tion (ChIP) assays, the chronological sequence of binding of
MafA, E47/b2 and PDX-1 to the insulin promoter in living
b-cells were investigated. All four factors were shown to bind
to the mouse insulin 2 promoter in a cyclical manner with a peri-
odicity of approximately 10–15 min. The cyclical binding of
MafA, E47 and b2 was largely unaﬀected by the glucose or insu-
lin concentration in the media. However, the binding and cycling
of PDX-1 was markedly abolished in low glucose (1 mM), and
this was reversed in the presence of low concentrations of insulin.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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mellitus1. Introduction
In the adult the insulin gene is expressed almost exclusively
in the b-cells of the pancreatic islets of Langerhans, although
extrapancreatic insulin has been detected at low levels in a
number of other tissues [1,2] including brain [3], thymus
[4–6], lachrymal glands [7] and salivary glands [8].
Whilst the DNA sequences involved in controlling expres-
sion of the gene in non-islet cells are largely uncharacterised,
those involved in b-cell speciﬁc expression have been mapped
in detail and shown to reside within 350 base pairs upstream
from the transcription start site [9]. In the b-cell, a number
of transcription factors bind to discrete cis-acting elements
within this region. These include the homeodomain protein
PDX-1 [10], the bHLH heterodimer E47/b2 [11] and the bZIP
protein MafA [12,13]. The arrangement of binding sites for
these factors is conserved between species with a particularly
well conserved cassette of C, E and A boxes, which bind
MafA, E47/b2 and PDX-1, respectively, located within a 60
nucleotide region close to the transcription start site.
Individually the three factors exhibit weak transcriptional ef-
fects on the promoter, but in combination they can exert
strong synergistic eﬀects [14–16]. In the human insulin gene,
however, where the spacing between elements diﬀers from that
in rodents and other lower species, PDX-1 has a dominant
transcriptional eﬀect, which is unaﬀected or at best weakly
aﬀected by E47/b2 or MafA [17].*Corresponding author. Fax: +44 1224 555844.
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doi:10.1016/j.febslet.2005.12.061The aim of this study was to understand better how these
four factors interact to control the insulin gene in living b-cells.
The approach was to use chromatin immunoprecipitation as-
says to study the order in which PDX-1, MafA and E47/b2
bind to the insulin promoter, and to determine whether the
binding kinetics might be modulated by glucose, high physio-
logical concentrations of which are known to stimulate insulin
gene transcription.2. Materials and methods
2.1. Cell culture
MIN-6 cells, [18] were maintained in monolayer culture on plastic
plates (Greiner, Stonehouse, UK) in Dulbecco’s modiﬁed Eagle’s min-
imum essential medium (DMEM) plus GlutaMAXe, and glucose
(4.5 g/l) (Invitrogen, Paisley, UK), and supplemented with 15% (v/v)
foetal bovine serum (Invitrogen) and 70 lM b-mercaptoethanol.
2.2. Chromatin immunoprecipitation (ChIP) assays
ChIP assays were performed as previously described [17]. Cells were
grown to 80% conﬂuency on 15 cm tissue culture plates. After treat-
ment formaldehyde was added to a ﬁnal concentration of 1% (vol/
vol) and following 10 min at 37 C, glycine was added to a ﬁnal con-
centration of 0.125 M. The medium was then removed and the cells
washed twice in phosphate buﬀered saline (PBS) containing 1 mM phe-
nyl methyl sulphonyl ﬂuoride, 1 mg/ml aprotinin and 1 mg/ml pepsta-
tin A. The cells were collected and resuspended in 1 ml SDS lysis buﬀer
containing 1% (w/v) SDS, 10 mM EDTA, 50 mM Tris/HCl, pH 8.1,
and protease inhibitors. The samples were incubated on ice for
10 min and sonicated with 20 · 10 s pulses using a Misonix S3000 soni-
cator with microtip at power setting 1.0. Following centrifugation at
13000 · g for 10 min at 4 C, the supernatant was divided into ﬁve
tubes and made up to 2 ml with ChIP dilution buﬀer containing
0.01% SDS, 1.1% (vol/vol) Triton X-100, 1.2 mM EDTA, 167 mM
NaCl, 16.7 mM Tris/HCl, pH 8.1, and protease inhibitors. 80 ll sal-
mon sperm DNA/Protein A slurry (Upstate, Milton Keynes, UK)
was added and the samples mixed for 30 min at 4 C on a rotating
wheel. After centrifugation, 10 lg of normal rabbit serum (Upstate),
anti-PDX-1 antibody (kind gift from C. Wright, Vanderbilt Univer-
sity, Nashville, TN, USA), anti-MafA antibody (Calbiochem, Notting-
ham, UK), anti-b2 antibody (Santa-Cruz, Calne, UK) and anti-E47
antibody (Santa-Cruz) were added to each supernatant and the sam-
ples incubated at 4 C overnight with rotation. Salmon sperm DNA/
Protein A slurry (60 ll) was added and the samples rotated at 4 C
for a further 1 h to capture the immune complexes. The agarose was
pelleted by centrifugation at 4 C for 1 min at 1000 · g and the super-
natant discarded. The agarose pellet was then washed once in low-salt
wash buﬀer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris/
HCl, pH 8.1, and 150 mM NaCl), once in high-salt wash buﬀer (0.1%
SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris/HCl, pH 8.1, and
500 mM NaCl), and once in LiCl wash buﬀer (0.25 M LiCl, 1% Ige-
pal-CA630, 1% deoxycholate, 1 mM EDTA and 10 mM Tris/HCl,
pH 8.1). The agarose was then washed twice in TE buﬀer (10 mM
Tris/HCl and 1 mM EDTA, pH 8.0) and the antibody-bound com-
plexes were eluted by incubation with rotation at room temperature
for 15 min in 500 ll 1% SDS and 0.1 M NaHCO3. The agarose wasblished by Elsevier B.V. All rights reserved.
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samples were heated at 65 C for 4 h to reverse the formaldehyde cross-
linking. 10 ll of 0.5 M EDTA, 20 ll of 1 M Tris/HCl, pH 6.5 and 2 ll
of 10 mg/ml proteinase K were added to the supernatant, and the sam-
ples were heated at 65 C for 4 h. Chromatin DNA was then extracted
in phenol/chloroform and precipitated in ethanol.
PCR was performed using TaqMan PCR probe sets (Applied Bio-
systems, Warrington, UK) coupled with SensiMixe PCR master mix
(Quantace). The mouse insulin 2 primers and probe sequences were:
forward 5 0 TAATTACCCTAGGACTAAGTAGAGGTGTTG 3 0, re-
verse 5 0 TTGACCCATTAAGGGCTCCA 3 0 and probe 5 0 ACGTC-
CAATGAGCGCT 3 0 with a FAM dye label. PCR reactions were
carried out and analysed using an MJ Research DNA Engine/Opticon
2 qPCR system.3. Results
The aim of the study was to determine the order in which
PDX-1, MafA, E47 and b2 bound to the insulin promoter
and attempt to establish the chronological sequence of events
that occur during initiation of insulin gene transcription in
the b-cell. The experiments were performed on mouse MIN6
b-cells, since these cells express and secrete higher levels of
insulin than most other b-cell lines [19] and also exhibit a ro-
bust response to glucose within the near-physiological range.
Unlike humans, there are two insulin genes in the mouse. Both
genes contain the highly conserved C–E–A cassette that lies in
close proximity to the transcription start site and binds MafA,
E47/b2 and PDX-1 (Fig. 1).
The strategy was to incubate the cells in 2.5 lM a-amanitin,
a toxin isolated from mushrooms that acts as a speciﬁc inhib-
itor of RNA polymerase II [20]. Preliminary experiments con-
ﬁrmed that under these conditions a-amanitin reduced mouse
insulin 2 mRNA, as measured by RT/PCR, by approximately
30%, which is in keeping with the long half-life of the mRNA
(data not shown). The object was to generate a synchronised
cell population in which the insulin promoter was eﬀectively
devoid of transcription factors [21]. Upon removal of a-amani-Fig. 1. Arrangement of C, E and A boxes in the insulin promoter. The top p
(140 to 70) of insulin genes from mouse, rat and human with the highly
sequence of the mouse insulin 2 promoter with MafA (C-box), E47/b2 (E-bo
(arrows) and probe (broken line) sequences used in the qPCR reactions.tin the subsequent binding of transcription factors to the
mouse insulin 2 promoter was analysed by ChIP assays using
antibodies speciﬁc for MafA, PDX-1, E47 and b2. A threshold
ﬂuorescence value was selected to provide quantiﬁable values
based on the linear range of the PCR ampliﬁcations (Fig. 2).
In order to enhance synchronisation in a growth-arrested
state the cells were cultured in low serum (0.2% vol/vol) for
72 h prior to treatment with a-amanitin. MIN-6 cells have a
doubling time of 48 h in medium containing 15% foetal bovine
serum. In 0.2% serum there was no increase in cell number or
any decrease in cell viability as measured by Trypan Blue exclu-
sion over 72 h (data not shown). The a-amanitin was removed
and the cells subsequently incubated for varying periods of time
in serum-free DMEM containing 25 mM glucose. Over a 60-
min period all four transcription factors bound to the promoter
in an oscillatory manner (Fig. 3) with the cycling frequency for
PDX-1 and MafA being approximately 10–15 min. The
amount of DNA immunoprecipitated with the E47 and b2 anti-
bodies was much less than that for MafA and PDX-1. Never-
theless, both E47 and b2 bound in a cyclical manner with a
frequency of 10–15 min. This oscillatory pattern of the DNA-
binding of MafA, PDX-1, and E47 was highly reproducible
(n = 6). However, the binding of b2 was consistently low, pos-
sibly because of the poor aﬃnity for the antibody, and oscilla-
tions, which appeared to be out of sync with the other factors,
were less obvious in some experiments.
Glucose, a major regulator of insulin gene expression, is
known to stimulate PDX-1 [22,23] and MafA [24–26] binding
to insulin promoter sequences. When cells were treated with
low serum and a-amanitin followed by incubation in medium
containing 1 mM glucose the binding of MafA to the promoter
was as strong as in high glucose, with maximal binding under
both conditions reaching around 20% of the input DNA
(Fig. 4). MafA also continued to cycle strongly in low glucose
with a frequency of 10, 15, 10 and 15 min. Low glucose had no
eﬀect on initial PDX-1 cycling or maximal binding activity,
which under low and high glucose conditions was approxi-anel shows an alignment of DNA sequences from the upstream region
conserved C, E and A boxes highlighted. The lower panel shows the
x) and PDX-1 (A-box) binding sites underlined, along with the primer
Fig. 2. Quantiﬁcation of DNA binding by qPCR analysis of immu-
noprecipitated chromatin. (A) Data generated when puriﬁed PCR
products from a typical ChIP assay were serially diluted in a 10-fold
dilution series from 104 to 108 and analysed by qPCR. The broken
horizontal line shows the threshold level of ﬂuorescence used to
quantify each sample. (B) PCR product displaying a linear reduction
over a dilution range of between 25 and 45 cycles.
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Fig. 3. Transcription factor cycling on the insulin promoter. MIN-6
cells were cultured in 15 cm tissue culture dishes for 72 h in DMEM
containing 0.2% serum and 25 mM glucose. a-Amanitin was added
directly to the culture medium to give a ﬁnal concentration of 2.5 lM
and the cells were incubated for 2 h at 37 C. The medium was
removed, the cells washed twice in PBS and 20 ml of serum-free
DMEM containing 25 mM glucose was added to each dish. Cells were
treated with formaldehyde at the indicated times and processed for
ChIP assays using the indicated antibodies. Results shown are the
qPCR data for mouse insulin 2 sequences. All ChIP assays were
carried out using a single chromatin preparation of each time point.
The values are expressed as % of input DNA and represent the mean of
6 qPCR reactions.
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Fig. 4. Eﬀect of low glucose (1 mM) on transcription factor cycling on
the insulin promoter. MIN-6 cells were cultured in 15 cm tissue culture
dishes for 48 h in DMEM containing 0.2% serum and 25 mM glucose
and then in DMEM containing 0.2% serum and 1 mM glucose for
24 h. a-Amanitin was added directly to the culture medium to give a
ﬁnal concentration of 2.5 lM and the cells were incubated for 2 h at
37 C. The medium was removed, the cells washed twice in PBS and
20 ml of serum-free DMEM containing 1 mM glucose was added to
each dish. Cells were treated with formaldehyde at the indicated times
and processed for ChIP assays using the indicated antibodies. Results
shown are the qPCR data for mouse insulin 2 sequences. All ChIP
assays were carried out using a single chromatin preparation of each
time point. The values are expressed as % of input DNA and represent
the mean of 6 qPCR reactions.
J. Barrow et al. / FEBS Letters 580 (2006) 711–715 713mately 6–8% of the input DNA. However, in marked contrast
to high glucose its binding activity decreased after 30 min to
<1% of input DNA. b2 binding activity in low glucose was
barely detectable (<0.2% of input), but E47 was stronger and
continued to exhibit oscillatory binding activity, although like
PDX-1 this tended to peter out at later time points.0
2
4
6
8
10
0 5 10 15 20 25 30 35 40 45 50 55 60
Time (min)
t
up
nI
 f
o
 
%
PDX-1
β2
E47
MafA
Fig. 5. Eﬀect of insulin (0.2 nM) on transcription factor cycling on the
insulin promoter. MIN-6 cells were cultured in 15 cm tissue culture
dishes for 48 h in DMEM containing 0.2% serum and 25 mM glucose
and then in DMEM containing 0.2% serum and 1 mM glucose for
24 h. a-Amanitin was added directly to the culture medium to give a
ﬁnal concentration of 2.5 lM and the cells were incubated for 2 h at
37 C. The medium was removed, the cells washed twice in PBS and
20 ml of serum-free DMEM containing 1 mM glucose and 0.2 nM
insulin was added to each dish. Cells were treated with formaldehyde
at the indicated times and processed for ChIP assays using the
indicated antibodies. Results shown are the qPCR data for mouse
insulin 2 sequences. All ChIP assays were carried out using a single
chromatin preparation of each time point. The values are expressed as
% of input DNA and represent the mean of 6 qPCR reactions.
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expression [27] in part through its eﬀects on PDX-1 DNA
binding activity [28]. In the presence of low glucose (1 mM),
insulin (0.2 nM) re-instated PDX-1 DNA-binding activity be-
yond 30 min (Fig. 5). In addition, the three transcription fac-
tors MafA, E47 and b2 also showed clear cycling after
45 min that was completely lacking in low glucose alone. This
was especially true of MafA, which had more pronounced cy-
cling between 45 and 60 min in insulin treated cells than in cells
cultured in either high or low glucose.4. Discussion
The major ﬁndings of this study were that MafA, E47, b2
and PDX-1 bound to the mouse insulin 2 promoter in a cycli-
cal manner with a periodicity of approximately 10–15 min. The
cyclical binding of MafA, E47 and b2 was largely unaﬀected by
the glucose or insulin concentration in the media. However,
the binding and cycling of PDX-1 was markedly abolished in
low glucose (1 mM), although there was a lag of approxi-
mately 30 min, or two cycles, before this eﬀect was observed.
Insulin, at low concentrations (0.2 nM) reversed the inhibitory
eﬀects of low glucose on PDX-1 binding and cycling.
Pulsatile binding of transcription factors has been reported in
other systems. NFjB activation of gene expression occurs in an
oscillatory manner regulated by a negative feed-back loop
involving Ijb isoforms [29,30]. Dependent on the rate of nucle-
ar import and Ijb breakdown, the pulse frequency of about 2–
4 h depending on the activating signal is very diﬀerent from the
one reported in the present paper. The shorter pulse frequency
reported here is more reminiscent of hormone secretion. In the
case of insulin, secretory pulses occur at regular intervals that
vary from 4 to 15 min when measured in vivo to 6–10 min
in vitro [31]. Insulin secretory pulses are generated through
the combined action of metabolic, i.e., glycolytic, oscillations
[32] and oscillations in intracellular [Ca2+] [33], with calcium
acting in a dominant role [34]. In the b-cell, calcium controls
numerous processes, including insulin gene expression [35]. It
is possible that the pulsatile binding of transcription factors
to the insulin promoter is regulated by calcium signalling in
the nucleus [36,37], possibly through the localised actions of
KATP channels present in the nuclear membrane [38].
Activation of the oestrogen receptor leads to a cyclical and
ordered recruitment of at least 30 diﬀerent proteins to the
pS2 promoter with a cycling frequency of about 10 min [21].
Over extended time periods (up to 160 min) three diﬀerent
types of cycle of protein recruitment could be identiﬁed. It will
be of interest to extend the study on the insulin gene to deter-
mine whether similar cycles relating to the recruitment of his-
tone modifying enzymes, general transcription factors and
accessory proteins can be identiﬁed.
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